The trial is the first controlled trial using the new FDA-cleared ultrasound UltraGuideCTR and real-time ultrasound guidance.
“I believe this technique is the biggest game changer in how carpal tunnel will be treated. I look forward to using this minimally invasive approach to help patients recover faster and return to enjoying the activities they couldn’t do prior to being treated,” Dr. Watt said in an Aug. 9 news release from Sonex Health, which claims the UltraGuideCTR as its first proprietary technology.
The ultrasound technology allows surgeons to operate on patients with carpal tunnel syndrome by making a small incision in their palms. The technology is expected to allow patients to recover within days instead of weeks or months, according to the news release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
